NCT07513129 2026-04-13A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And LymphomasM.D. Anderson Cancer CenterPhase 1 Not yet recruiting18 enrolled
NCT06253637 2026-03-05DARATALL-VHRGruppo Italiano Malattie EMatologiche dell'AdultoPhase 2 Active not recruiting31 enrolled